Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
about
Modern retinal laser therapyHistological findings of surgically excised choroidal neovascular membranes after photodynamic therapyTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapySelective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.Scanning laser system for photodynamic therapy of choroidal neovascularization.Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins.Age-related macular degeneration: epidemiology and optimal treatment.Age-related macular degeneration. Can we stem this worldwide public health crisis?Laser targeted photo-occlusion of rat choroidal neovascularization without collateral damage.Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells.Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model.Macrophages inhibit neovascularization in a murine model of age-related macular degenerationPhotodynamic therapy of experimental choroidal neovascularization in the mouse.Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo.Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).Review of the ocular angiogenesis animal models.Current treatments for radiation retinopathy.Combined photodynamic therapy and intravitreal bevacizumab injection for the treatment of adult Coats' disease: a case report.An in silico model of retinal cholesterol dynamics (RCD model): insights into the pathophysiology of dry AMDIndocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization.Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degenerationLucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration.Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization.The ins and outs of cholesterol in the vertebrate retina.Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.Improvement and optimization of standards for a preclinical animal test model of laser induced choroidal neovascularizationPlasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration.Vascular endothelial growth factor and ocular neovascularization.Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration.Photodynamic therapy: current role in the treatment of chorioretinal conditionsPhotodynamic therapy with verteporfin: a new treatment in ophthalmology.Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: from clinical trials to clinical practice.Development of verteporfin therapy: a collaboration between pharmaceutical companies, device manufacturers and clinical investigators.New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence.Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinoloneManagement of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT) - a holistic approach.
P2860
Q26823096-86EEEAF5-714A-4FCB-84CB-581C645B5B1DQ28346640-12E6BC62-A268-4C84-8711-2F7593A066D8Q28361141-D01985E7-13E6-4D43-8113-68BB5360845FQ30680509-4ACF0EE7-605D-4124-94D5-19225DDACBE7Q30738483-917B6CA3-293F-434D-B20C-61E2897086D1Q30833043-1D09DB04-B652-4AB9-A2B0-C652690A3C05Q30877374-DFFE5118-D02C-4792-B91D-1DB3A31DF867Q31048292-619ED3C6-8D0E-4D3B-AF3C-428A18D07404Q32063590-26D6A176-2C04-4F33-9FFA-37773C7656A5Q32065443-F127C156-06E4-4FC9-8682-B159AEA39445Q33199573-676116DD-E25A-4B94-9558-83D82276B68BQ33231968-685309F9-ABB0-46BA-BFCD-F969F7A3599DQ33253660-9176A346-F3E7-4A7C-B50E-08E888F69E4CQ33257172-5BD0BD8C-B894-401B-B09C-3153395C16BDQ33279027-5E5C6A46-3780-4068-B15A-5C404AB457CCQ33393258-7FC7E24D-2ED3-4F77-AF93-FC86F08118E2Q33416828-7A3573F4-13D9-404F-9679-F154985D6894Q33431314-17439046-2789-4C6A-A439-500DA94D4934Q33665180-375B920F-844A-435A-AB48-E930D3A0B7C9Q33774296-0317EB8C-6B3F-4D43-938A-C98907759677Q33867675-FA4257AE-6F5A-43CA-8186-A1228C65CF2EQ33903284-90545465-224D-4E21-9F6A-6A08F5B2DD98Q34116399-DDCF2EE9-60B7-4A52-BCF8-B12C5A929FC4Q34188239-9D676F2D-8C4C-435B-8EB6-04CA47F03760Q34210541-1DB10659-6A43-40A1-8503-D8688A412834Q34276196-FE45F396-9F28-4324-B26A-4017A3F01095Q34287793-4A693DE2-FD01-49FC-8DD5-C30C1F6995D7Q34419492-7F4684E6-FA51-4F8D-ABFB-E30366F9D224Q35159767-91343427-C028-4E26-BE81-1CFD2076DD90Q35540652-23DC6A9F-0626-437B-B4E3-E5CF60A7CED6Q35763668-69BCBE34-E651-4A24-AE16-E769C69CD6FCQ35842575-634DEA3F-2336-4F1C-8CA8-B24F8F1BDEBFQ35888341-366E3F7C-5937-41E3-A4FE-83D090291A6DQ35932473-B829B4DF-F78A-41FB-ACA4-A9804042D8ABQ35932478-AC324232-E125-471A-BF22-1BB8B72E709CQ35932482-18D615AB-C539-40E0-932A-58F4B7BBC9C8Q36715897-A62A13DB-CD8E-49D6-8708-1EDD6A97B5E0Q41278020-192C6AFD-A308-48ED-82F1-963E5317FA4DQ41350550-AC21FDE7-9854-4076-A24E-FF7A4F330625Q51358592-19342C3D-6FE5-4040-B5CC-B94792849732
P2860
Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@ast
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@en
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@nl
type
label
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@ast
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@en
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@nl
prefLabel
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@ast
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@en
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@nl
P2093
P1433
P1476
Photodynamic therapy of experi ...... tein-delivered benzoporphyrin.
@en
P2093
E S Gragoudas
J W Miller
R Haimovici
T J Flotte
P304
P356
10.1001/ARCHOPHT.1995.01100060136048
P407
P577
1995-06-01T00:00:00Z